...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Development and characterization of nanocapsules comprising dodecyltrimethylammonium chloride and κ-carrageenan
【24h】

Development and characterization of nanocapsules comprising dodecyltrimethylammonium chloride and κ-carrageenan

机译:包含十二烷基三甲基氯化铵和κ-角叉菜胶的纳米胶囊的开发与表征

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this work was to develop and characterize a new type of nanocapsules. To this end, a nanoemulsion bearing an oily core (Miglyol 812) was obtained by spontaneous emulsification and stabilized by dodecyl-trimethylammonium chloride (DTAC), a commercial cationic surfactant; this nanoemulsion was coated with proportionally very small amounts of κ-carrageenan (at molar charge ratios of Z≤ 0.0045) that interact predominantly by an electrostatic mechanism with the positively charged sites at the polar heads of DTAC at the nanoemulsion's surface to harness nanocapsules of average size ~250-330. nm and zeta potential (ζ) ranging from ~+80 to +7. mV. The potential application of the new type of developed nanosystems as drug delivery vehicles has yet to be investigated and fully realized.
机译:这项工作的目的是开发和表征新型的纳米胶囊。为此,通过自发乳化得到带有油性核的纳米乳液(Miglyol 812),并用十二烷基三甲基氯化铵(DTAC)(一种阳离子表面活性剂)稳定化。这种纳米乳剂按比例涂覆了非常少量的κ-角叉菜胶(摩尔电荷比为Z≤0.0045),这些蛋白主要通过静电作用与纳米乳剂表面的DTAC极性头上带正电荷的部位相互作用,以利用中等大小的纳米胶囊尺寸〜250-330。 nm和Zeta电位(ζ)在〜+ 80至+7之间。毫伏新型开发的纳米系统作为药物输送工具的潜在应用尚待研究和充分认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号